Back to top

Polyrizon completes clinical site network for NASARIX study

Polyrizon (PLRZ) has completed contracting with the fourth and fifth clinical sites participating in its clinical study of NASARIX Allergy Blocker....

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE: